Curis

CRISNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$5.837 M

$0.87 -21.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Curis (CRIS) has a market capitalization of $5.84M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$9.44M

#3144 by revenue

Earnings

-$7.58M

Loss-making

Shares outstanding

2,090,077

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#152Senti BiosciencesSNTI$6.33M
#153AIM ImmunoTechAIM$6.14M
#154CurisCRIS$5.84M
#155Creative Medical TechnologyCELZ$4.63M
#156Black TitanBTTC$4.33M

What if Curis were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,227,565

Per share 4,837,584× higher

Bitcoin $1.53T

$228,746.18

Per share 261,753× higher

Apple $5.02T

$750,952.36

Per share 859,312× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Curis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.